Effect of a novel nicotinic receptor antagonist, N,N′-dodecane-1,12- diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats

Psychopharmacology

Volumn 184, Issue 3-4, 2006, Pages 426-434

  Neugebauer, N M ^a   Zhang, Z ^b   Crooks, P A ^b   Dwoskin, L P ^b   Bardo, M T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

bPiDDB; Locomotor activity; Mecamylamine; Nicotine; Nicotinic receptor antagonist; Self administration; Tobacco dependence

Indexed keywords

BROMINE DERIVATIVE; DOPAMINE; MECAMYLAMINE; N,N' DODECANE 1,12 DIYLBIS 3 PICOLINIUM DIBROMIDE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; HYPERACTIVITY; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOBACCO DEPENDENCE;

ANIMALS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MECAMYLAMINE; MOTIVATION; MOTOR ACTIVITY; NICOTINE; NICOTINIC ANTAGONISTS; PICOLINES; PREMEDICATION; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SUCROSE;

EID: 32844461047     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0163-8     Document Type: Conference Paper

References (30)

1. Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA (2002) bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors. Bioorg Med Chem Lett 12:3067-3071
2. Balfour DJ, Benwell ME, Birrell CE, Kelly RJ, Al-Aloul M (1998) Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol Biochem Behav 59:1021-1030
3. Benwell ME, Balfour DJ (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
4. Clarke PB, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337
5. Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99:473-478
6. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107:285-289
7. Cummings KM, Hyland A (2004) Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health
8. Damaj MI, Martin BR (1993) Is the dopaminergic system involved in the central effects of nicotine in mice? Psychopharmacology (Berl) 111:106-108
9. Dews PB (1955) Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther 113:393-401
10. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147:135-142
11. Dwoskin LP, Sumithran SP, Zhu J, Deaciuc AG, Ayers JT, Crooks PA (2004) Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents. Bioorg Med Chem Lett 14:1863-1867
12. Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM (1999) Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl) 147:25-26
13. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000) Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119
14. Ksir C (1994) Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis. Psychopharmacology (Berl) 115:105-109
15. Lundahl LH, Henningfield JE, Lukas SE (2000) Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers. Pharmacol Biochem Behav 66:637-643
16. Markou A, Paterson NE (2001) The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 3:361-373
17. Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP (2001) Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology (Berl) 156:469-476
18. Miller DK, Sumithran SP, Dwoskin LP (2002) Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine. J Pharmacol Exp Ther 302:1113-1122
19. Morrison CF (1967) Effects of nicotine on operant behaviour of rats. Int J Neuropharmacol 6:229-240
20. Panagis G, Kastellakis A, Spyraki C, Nomikos G (2000) Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology (Berl) 149:388-396
21. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) 167:257-264
22. Phillips G, Willner P, Sampson D, Nunn J, Muscat R (1991) Time-, schedule-, and reinforcer-dependent effects of pimozide and amphetamine. Psychopharmacology (Berl) 104:125-134
23. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177
24. Rauhut AS, Mullins SN, Dwoskin LP, Bardo MT (2002) Reboxetine: attenuation of intravenous nicotine self-administration in rats. J Pharmacol Exp Ther 303:664-672
25. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56:86-99
26. Rose JE, Westman EC, Behm FM, Johnson MP, Goldberg JS (1999) Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav 62:165-172
27. Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129:35-43
28. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321-327
29. 3H] -overflow from rat striatal slices preloaded with [3H] -dopamine. J Pharmacol Exp Ther 283:778-787
30. Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62:743-751